Cosentyx

Cosentyx (secukinumab) is a subcutaneous medication used to manage moderate to severe plaque psoriasis and other inflammatory conditions. This biologic therapy targets specific proteins to help reduce symptoms.

Cosentyx is primarily used for the treatment of moderate to severe plaque psoriasis. It may also be prescribed for other inflammatory conditions such as psoriatic arthritis and ankylosing spondylitis. The medication works by targeting specific proteins in the body to help reduce inflammation and improve symptoms.

Common effects of Cosentyx may include redness, itching, or swelling at the injection site. Some users might experience headaches, nausea, or fatigue. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Cosentyx should be stored as directed, typically at room temperature away from light and moisture. It is important to follow the prescribed dosage and administration instructions. Users with a history of infections or allergies should inform their healthcare provider before starting treatment.

Cosentyx may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy or safety of Cosentyx.